| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 0.0005 |